Edition:
United States

Zhejiang Medicine Co Ltd (600216.SS)

600216.SS on Shanghai Stock Exchange

12.00CNY
29 Mar 2017
Change (% chg)

¥-0.31 (-2.52%)
Prev Close
¥12.31
Open
¥12.31
Day's High
¥12.36
Day's Low
¥11.99
Volume
20,401,608
Avg. Vol
9,721,258
52-wk High
¥15.91
52-wk Low
¥11.30

Latest Key Developments (Source: Significant Developments)

Kaneka wins lawsuit regarding patent infringement in US
Thursday, 26 Jan 2017 04:56am EST 

Kaneka Corp <4118.T>: Says the co won the lawsuit against Zhejiang Medicine Co. Ltd <600216.SS> and ZMC-USA, LLC. .Says the lawsuit regarding patent infringement of oxidized coenzyme Q10(KanekaQ10™) in the U.S..  Full Article

Zhejiang Medicine to pay 2015 div on July 18
Friday, 8 Jul 2016 01:53am EDT 

Zhejiang Medicine <600216.SS> Co., Ltd.: Says it will pay cash dividend of 0.5 yuan per 10 shares (before tax) to shareholders for 2015 as a record of July 15 .Says the company's shares will be traded ex-right and ex-dividend on July 18 and the dividend will be paid on July 18.  Full Article

Zhejiang Medicine announces 2015 dividend payment
Wednesday, 27 Apr 2016 08:00pm EDT 

Zhejiang Medicine Co Ltd:To pay cash dividend of 0.5 yuan per 10 shares (before tax) to shareholders for 2015.  Full Article

Zhejiang Medicine obtains drug clinical trial permission
Monday, 7 Mar 2016 07:00pm EST 

Zhejiang Medicine Co Ltd:Obtains antineoplastic drug clinical trial permission, for XCCS605B and XCCS605B for injection.  Full Article

Zhejiang Medicine signs strategic cooperation framework agreement
Monday, 7 Mar 2016 07:00pm EST 

Zhejiang Medicine Co Ltd:Signed a strategic cooperation framework agreement with Zhejiang Huahai Pharmaceutical Co., Ltd's wholly owned subsidiary in United States.The parties will cooperate in drug production, sales, research and development, registration and international certification, etc.  Full Article

Zhejiang Medicine to withdraw the drug registration application
Thursday, 21 Jan 2016 07:00pm EST 

Zhejiang Medicine Co Ltd:To withdraw the cefaclor capsule drug registration application.  Full Article

Zhejiang Medicine subsidiary to jointly develop hog cholera vaccine with subsidiary of Inner Mongolia Jinyu Group
Wednesday, 2 Dec 2015 07:00pm EST 

Zhejiang Medicine Co Ltd:Zhejiang-based subsidiary to jointly develop hog cholera vaccine with a Beijing-based biotech company and a subsidiary of Inner Mongolia Jinyu Group.Beijing-based biotech company to hold 46 pct right.Subsidiary to hold 44 pct right.Cooperation period of 18 months.  Full Article

Zhejiang Medicine announces 2014 dividend payment date
Thursday, 16 Jul 2015 08:00pm EDT 

Zhejiang Medicine Co Ltd:To pay cash dividend of 0.6 yuan per 10 shares (before tax) to shareholders for 2014 as a record of July 22.The company's shares will be traded ex-right and ex-dividend on July 23 and the dividend will be paid on July 23.  Full Article

Zhejiang Medicine announces 2014 dividend payment
Friday, 24 Apr 2015 08:00pm EDT 

Zhejiang Medicine Co Ltd:To pay cash dividend of 0.6 yuan per 10 shares (before tax) to all shareholders for 2014.  Full Article

More From Around the Web

BRIEF-Kaneka wins lawsuit regarding patent infringement in US

* Says the co won the lawsuit against Zhejiang Medicine Co. Ltd and ZMC-USA, LLC.